左心室辅助装置植入后右心衰竭的ECMO支持
结论认为临时ECMO辅助右心支持与良好的远期结局和高右心恢复率相关。
要点
- 左心室辅助装置植入后右心衰竭接受临时ECMO支持,90.6%患者右心恢复并成功脱离ECMO。
- ECMO支持中位3天,改善右心功能及血流动力学指标。
核心结论
- 临时ECMO辅助右心支持与良好的远期结局和高右心恢复率相关。
研究设计与样本
- 回顾性分析2009年5月至2014年4月连续32例左心室辅助装置植入后围术期右心衰竭接受临时ECMO支持的患者。
主要发现
- ECMO支持中位3天(范围1-15天),改善右心功能及血流动力学参数:中心静脉压13 mmHg vs 10 mmHg(P<0.01),平均肺动脉压28 mmHg vs 21 mmHg(P<0.01),心输出量5.1 l/min vs 5.9 l/min(P=0.09)。
- 死亡原因包括多器官功能障碍综合征(50%)、脓毒症(25%)、出血性卒中(12.5%)和缺血性卒中(12.5%)。
- ECMO支持期间死亡原因为缺血性卒中、脓毒症和多器官功能障碍综合征。
临床怎么用
- 对于左心室辅助装置植入后围术期右心衰竭,可考虑临时ECMO支持作为传统临时右心支持的替代方案。
局限性
- 本研究为单中心回顾性研究,样本量较小(32例),缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Right ventricular (RV) failure complicating left ventricular assist device implantation is associated with increased mortality. Despite a lack of supporting evidence, venoarterial extracorporeal membrane oxygenation (ECMO) support is increasingly being used as an alternative to traditional temporary RV support. We report our institutional experience with ECMO-facilitated RV support after left ventricular assist device implantation. METHODS: We retrospectively reviewed the concept of temporary ECMO support for perioperative RV failure in 32 consecutive left ventricular assist device (mean age 52 ± 14 years; male 84.4%; ischaemic cardiomyopathy 40.6%; INTERMACS Level I 71.8%; INTERMACS Level II 6.3%; INTERMACS Level III 12.5%; INTERMACS Level IV-VII 9.4%; HeartWare ventricular assist device 75%; HeartMate II: 25%) from May 2009 to April 2014. The study end points were RV recovery during ECMO support, mortality and causes of death. RESULTS: Twenty-nine (90.6%) patients were successfully weaned from ECMO support after RV recovery. Three (9.4%) patients expired during ECMO support. ECMO support improved RV function and haemodynamic parameters (central venous pressure 13 mmHg vs 10 mmHg, P < 0.01; mean pulmonary artery pressure 28 mmHg vs 21 mmHg, P < 0.01; cardiac output 5.1 l/min vs 5.9 l/min, P = 0.09) over a median period of 3 (range 1-15) days. Thirty-day and in-hospital mortality were 18.8% and 25%, respectively. One-year survival was 75%, causes of death were multiorgan dysfunction syndrome (50%), sepsis (25%), haemorrhagic stroke (12.5%) and ischaemic stroke (12.5%). Causes of death during ECMO support were ischaemic stroke, sepsis and multiorgan dysfunction syndrome. CONCLUSIONS: Temporary ECMO-facilitated RV support is associated with good long-term outcomes and high rates of RV recovery.
引用
- Riebandt J, Haberl T, Wiedemann D, et al. Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg. 2018. PMID: 29045747. doi:10.1093/ejcts/ezx349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。